FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079876639> ?p ?o ?g. }

• W2079876639 endingPage "46" @default.
• W2079876639 startingPage "39" @default.
• W2079876639 abstract "OBJECTIVE The National Institute of Neurological Disorders and Stroke (NINDS) Recombinant Tissue Plasminogen Activator Stroke Study Group showed that recombinant tissue plasminogen activator (rt-PA) administered intravenously within 3 hours of the onset of ischemic stroke can improve clinical outcome. Intraarterial (IA) thrombolysis has been shown to offer advantages over intravenous (IV) thrombolysis, but experience with this type of therapy within 3 hours of the onset of symptoms has not been reported previously. This study is the first retrospective analysis of a two-institution experience with IA thrombolysis within 3 hours of stroke onset. METHODS A total of 36 patients with angiographically demonstrated occlusions were treated with urokinase or rt-PA within 3 hours of stroke onset. Outcome measures included the percentage of patients with no or minimal neurological disability at 30 to 90 days as measured by the modified Rankin Scale, percentage recanalization, incidence of symptomatic intracranial hemorrhage, and mortality rate. The results were compared with those of the NINDS rt-PA study. RESULTS The median admission National Institutes of Health Stroke Scale score was 14. Fifty percent of treated patients had a modified Rankin Scale score of 0 or 1 indicating no or little disability at 1 to 3 months compared with 39% of treated patients in the NINDS trial. Recanalization was 75%, symptomatic intracranial hemorrhage was 11% (versus 6.4% with IV rt-PA in the NINDS trial), and the mortality rate was 22% (versus 17% with IV rt-PA in the NINDS trial). CONCLUSION The results suggest that IA thrombolysis administered within 3 hours of stroke onset is a feasible and viable alternative to IV rt-PA on the basis of improved clinical outcomes, high recanalization percentage, and comparable mortality rate and despite increased symptomatic intracranial hemorrhage. Whether IA thrombolysis is superior to IV therapy awaits further study." @default.
• W2079876639 created "2016-06-24" @default.
• W2079876639 creator A5000156377 @default.
• W2079876639 creator A5024890057 @default.
• W2079876639 creator A5060831304 @default.
• W2079876639 creator A5065288339 @default.
• W2079876639 creator A5072342187 @default.
• W2079876639 creator A5083580888 @default.
• W2079876639 date "2004-01-01" @default.
• W2079876639 modified "2023-10-13" @default.
• W2079876639 title "Intraarterial Thrombolytic Therapy within 3 Hours of the Onset of Stroke" @default.
• W2079876639 cites W1972187733 @default.
• W2079876639 cites W1973982955 @default.
• W2079876639 cites W2014739346 @default.
• W2079876639 cites W2030340828 @default.
• W2079876639 cites W2035524627 @default.
• W2079876639 cites W2039392119 @default.
• W2079876639 cites W2040120906 @default.
• W2079876639 cites W2051057357 @default.
• W2079876639 cites W2051930584 @default.
• W2079876639 cites W2055406113 @default.
• W2079876639 cites W2059217502 @default.
• W2079876639 cites W2066775145 @default.
• W2079876639 cites W2071984852 @default.
• W2079876639 cites W2074189342 @default.
• W2079876639 cites W2081769749 @default.
• W2079876639 cites W2098032054 @default.
• W2079876639 cites W2099706007 @default.
• W2079876639 cites W2118738743 @default.
• W2079876639 cites W2121695774 @default.
• W2079876639 cites W2128811888 @default.
• W2079876639 cites W2139399125 @default.
• W2079876639 cites W2143631659 @default.
• W2079876639 cites W2146307187 @default.
• W2079876639 cites W2292308933 @default.
• W2079876639 cites W2415927457 @default.
• W2079876639 cites W4250104750 @default.
• W2079876639 doi "https://doi.org/10.1227/01.neu.0000097197.61376.05" @default.
• W2079876639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14683539" @default.
• W2079876639 hasPublicationYear "2004" @default.
• W2079876639 type Work @default.
• W2079876639 sameAs 2079876639 @default.
• W2079876639 citedByCount "31" @default.
• W2079876639 countsByYear W20798766392012 @default.
• W2079876639 countsByYear W20798766392013 @default.
• W2079876639 crossrefType "journal-article" @default.
• W2079876639 hasAuthorship W2079876639A5000156377 @default.
• W2079876639 hasAuthorship W2079876639A5024890057 @default.
• W2079876639 hasAuthorship W2079876639A5060831304 @default.
• W2079876639 hasAuthorship W2079876639A5065288339 @default.
• W2079876639 hasAuthorship W2079876639A5072342187 @default.
• W2079876639 hasAuthorship W2079876639A5083580888 @default.
• W2079876639 hasConcept C126322002 @default.
• W2079876639 hasConcept C127413603 @default.
• W2079876639 hasConcept C141071460 @default.
• W2079876639 hasConcept C2776572282 @default.
• W2079876639 hasConcept C2776892390 @default.
• W2079876639 hasConcept C2777094939 @default.
• W2079876639 hasConcept C2777736543 @default.
• W2079876639 hasConcept C2779581417 @default.
• W2079876639 hasConcept C2780645631 @default.
• W2079876639 hasConcept C2780931571 @default.
• W2079876639 hasConcept C2909817843 @default.
• W2079876639 hasConcept C2911092318 @default.
• W2079876639 hasConcept C3020199598 @default.
• W2079876639 hasConcept C42219234 @default.
• W2079876639 hasConcept C500558357 @default.
• W2079876639 hasConcept C541997718 @default.
• W2079876639 hasConcept C71924100 @default.
• W2079876639 hasConcept C78519656 @default.
• W2079876639 hasConceptScore W2079876639C126322002 @default.
• W2079876639 hasConceptScore W2079876639C127413603 @default.
• W2079876639 hasConceptScore W2079876639C141071460 @default.
• W2079876639 hasConceptScore W2079876639C2776572282 @default.
• W2079876639 hasConceptScore W2079876639C2776892390 @default.
• W2079876639 hasConceptScore W2079876639C2777094939 @default.
• W2079876639 hasConceptScore W2079876639C2777736543 @default.
• W2079876639 hasConceptScore W2079876639C2779581417 @default.
• W2079876639 hasConceptScore W2079876639C2780645631 @default.
• W2079876639 hasConceptScore W2079876639C2780931571 @default.
• W2079876639 hasConceptScore W2079876639C2909817843 @default.
• W2079876639 hasConceptScore W2079876639C2911092318 @default.
• W2079876639 hasConceptScore W2079876639C3020199598 @default.
• W2079876639 hasConceptScore W2079876639C42219234 @default.
• W2079876639 hasConceptScore W2079876639C500558357 @default.
• W2079876639 hasConceptScore W2079876639C541997718 @default.
• W2079876639 hasConceptScore W2079876639C71924100 @default.
• W2079876639 hasConceptScore W2079876639C78519656 @default.
• W2079876639 hasIssue "1" @default.
• W2079876639 hasLocation W20798766391 @default.
• W2079876639 hasLocation W20798766392 @default.
• W2079876639 hasOpenAccess W2079876639 @default.
• W2079876639 hasPrimaryLocation W20798766391 @default.
• W2079876639 hasRelatedWork W2048612947 @default.
• W2079876639 hasRelatedWork W2171891409 @default.
• W2079876639 hasRelatedWork W2342256744 @default.
• W2079876639 hasRelatedWork W2351392355 @default.
• W2079876639 hasRelatedWork W2366727689 @default.

• next